Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Total
Beginning Balance at Jun. 30, 2024 $ 1,582 $ 820,337 $ 1,325,247 $ (78,316) $ 2,068,850
Balances (in shares) at Jun. 30, 2024 158,216,000        
Net earnings     33,600   33,600
Other comprehensive income       18,229 18,229
Common stock issued for exercise of options $ 6 23,224 (2,338)   20,892
Common stock issued for exercise of options (in shares) 577,000        
Common stock issued for restricted stock awards $ 1 1 (2,646)   (2,644)
Common stock issued for restricted stock awards (in shares) 50,000        
Cash dividends     (12,688)   (12,688)
Stock-based compensation expense   10,146     10,146
Common stock issued to employee stock purchase plan $ 0 2,227     2,227
Common stock issued to employee stock purchase plan (in shares) 35,000        
Employee stock purchase plan expense   38     38
Ending Balance at Sep. 30, 2024 $ 1,589 855,973 1,341,175 (60,087) 2,138,650
Balances (in shares) at Sep. 30, 2024 158,878,000        
Beginning Balance at Jun. 30, 2024 $ 1,582 820,337 1,325,247 (78,316) 2,068,850
Balances (in shares) at Jun. 30, 2024 158,216,000        
Net earnings         68,490
Other comprehensive income         $ (7,334)
Common stock issued for exercise of options (in shares)         800,000
Ending Balance at Dec. 31, 2024 $ 1,579 875,864 1,286,699 (85,650) $ 2,078,492
Balances (in shares) at Dec. 31, 2024 157,916,000        
Beginning Balance at Sep. 30, 2024 $ 1,589 855,973 1,341,175 (60,087) 2,138,650
Balances (in shares) at Sep. 30, 2024 158,878,000        
Net earnings     34,890   34,890
Other comprehensive income       (25,563) (25,563)
Share repurchases $ (11)   (75,617)   (75,628)
Share repurchases (in shares) (1,118,000)        
Common stock issued for exercise of options $ 1 5,183 (20)   5,164
Common stock issued for exercise of options (in shares) 132,000        
Common stock issued for restricted stock awards $ 0 0 (993)   (993)
Common stock issued for restricted stock awards (in shares) 24,000        
Cash dividends     (12,736)   (12,736)
Stock-based compensation expense   14,335     14,335
Employee stock purchase plan expense   373     373
Ending Balance at Dec. 31, 2024 $ 1,579 875,864 1,286,699 (85,650) 2,078,492
Balances (in shares) at Dec. 31, 2024 157,916,000        
Beginning Balance at Jun. 30, 2025 $ 1,550 911,089 1,066,049 (59,880) $ 1,918,808
Balances (in shares) at Jun. 30, 2025 154,972,000       154,972,196
Net earnings     38,185   $ 38,185
Other comprehensive income       (4,515) (4,515)
Share repurchases $ 0   (24)   (24)
Share repurchases (in shares) (1,000)        
Common stock issued for exercise of options $ 6 21,477 (5,895)   15,588
Common stock issued for exercise of options (in shares) 625,000        
Common stock issued for restricted stock awards $ 1 (1) (3,337)   (3,337)
Common stock issued for restricted stock awards (in shares) 110,000        
Cash dividends     (12,444)   (12,444)
Stock-based compensation expense   11,543     11,543
Common stock issued to employee stock purchase plan $ 0 2,012     2,012
Common stock issued to employee stock purchase plan (in shares) 43,000        
Employee stock purchase plan expense   (2)     (2)
Ending Balance at Sep. 30, 2025 $ 1,557 946,118 1,082,534 (64,395) 1,965,814
Balances (in shares) at Sep. 30, 2025 155,749,000        
Beginning Balance at Jun. 30, 2025 $ 1,550 911,089 1,066,049 (59,880) $ 1,918,808
Balances (in shares) at Jun. 30, 2025 154,972,000       154,972,196
Net earnings         $ 76,194
Other comprehensive income         $ (2,464)
Common stock issued for exercise of options (in shares)         1,500,000
Ending Balance at Dec. 31, 2025 $ 1,559 964,955 1,106,819 (62,344) $ 2,010,989
Balances (in shares) at Dec. 31, 2025 155,881,000       155,881,291
Beginning Balance at Sep. 30, 2025 $ 1,557 946,118 1,082,534 (64,395) $ 1,965,814
Balances (in shares) at Sep. 30, 2025 155,749,000        
Net earnings     38,009   38,009
Other comprehensive income       2,051 2,051
Common stock issued for exercise of options $ 1 4,738     4,739
Common stock issued for exercise of options (in shares) 100,000        
Common stock issued for restricted stock awards $ 1 (1) (1,254)   (1,254)
Common stock issued for restricted stock awards (in shares) 32,000        
Cash dividends     (12,470)   (12,470)
Stock-based compensation expense   13,727     13,727
Employee stock purchase plan expense   373     373
Ending Balance at Dec. 31, 2025 $ 1,559 $ 964,955 $ 1,106,819 $ (62,344) $ 2,010,989
Balances (in shares) at Dec. 31, 2025 155,881,000       155,881,291